Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Prepaid Assets: 2018-2025

Historic Prepaid Assets for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to $2.4 million.

  • Whitehawk Therapeutics' Prepaid Assets fell 9.26% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 9.26%. This contributed to the annual value of $2.8 million for FY2024, which is 25.88% down from last year.
  • As of Q3 2025, Whitehawk Therapeutics' Prepaid Assets stood at $2.4 million, which was up 65.81% from $1.5 million recorded in Q2 2025.
  • Whitehawk Therapeutics' Prepaid Assets' 5-year high stood at $4.4 million during Q1 2023, with a 5-year trough of $578,461 in Q2 2021.
  • In the last 3 years, Whitehawk Therapeutics' Prepaid Assets had a median value of $2.8 million in 2024 and averaged $2.9 million.
  • Over the last 5 years, Whitehawk Therapeutics' Prepaid Assets had its largest YoY gain of 2,718.52% in 2021, and its largest YoY loss of 65.16% in 2021.
  • Whitehawk Therapeutics' Prepaid Assets (Quarterly) stood at $2.3 million in 2021, then skyrocketed by 64.08% to $3.7 million in 2022, then climbed by 2.14% to $3.8 million in 2023, then dropped by 25.88% to $2.8 million in 2024, then dropped by 9.26% to $2.4 million in 2025.
  • Its Prepaid Assets was $2.4 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.6 million in Q1 2025.